The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Celgene Corp

Nasdaq: CELG
Last

(U.S.) $108.79

Today's change+0.88 +0.82%
Updated August 26 4:00 PM EDT. Delayed by at least 15 minutes.
 

Celgene Corp

Nasdaq: CELG
Last

(U.S.) $108.79

Today's change+0.88 +0.82%
Updated August 26 4:00 PM EDT. Delayed by at least 15 minutes.

Celgene Corp up (U.S.)$0.88

Celgene Corp closed up Friday by (U.S.)$0.88 or 0.82% to (U.S.)$108.79. Over the last five days, shares have lost 3.00% and are down 9.16% for the last year to date. This security has underperformed the S&P 500 by 20.53% during the last year.

Key company metrics

  • Open(U.S.) $107.93
  • Previous close(U.S.) $107.91
  • High(U.S.) $110.13
  • Low(U.S.) $107.50
  • Bid / Ask(U.S.) $106.00 / (U.S.) $111.55
  • YTD % change-9.16%
  • Volume4,728,358
  • Average volume (10-day)3,591,958
  • Average volume (1-month)4,468,215
  • Average volume (3-month)4,396,952
  • 52-week range(U.S.) $93.05 to (U.S.) $128.39
  • Beta1.31
  • Trailing P/E45.68×
  • P/E 1 year forward19.09×
  • Forward PEG0.87×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.38
Updated August 26 4:00 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue2,7542,5122,5632,334
Total other revenue--------
Total revenue2,7542,5122,5632,334
Gross profit2,6432,4062,4582,224
Total cost of revenue111106105110
Total operating expense1,9631,4881,6852,276
Selling / general / administrative732543609550
Research & development9497337771,305
Depreciation / amortization175928864
Interest expense (income), net operating--------
Unusual expense (income)-414105248
Other operating expenses, total--------
Operating income7921,02487958
Interest income (expense), net non-operating-136-135-139-105
Gain (loss) on sale of assets--------
Other--------
Income before tax695922746-20
Income after tax598801561-34
Income tax, total9712118514
Net income598801561-34
Total adjustments to net income--------
Net income before extra. items598801561-34
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items598801561-34
Inc. avail. to common incl. extra. items598801561-34
Diluted net income598801561-34
Dilution adjustment--------
Diluted weighted average shares802808817791
Diluted EPS excluding extraordinary itemsvalue per share0.750.990.69-0.04
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share0.741.010.780.16